Clinical Trial: Can DW MRI Predict Outcome During Radiotherapy for Head and Neck Cancer?

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Study of Diffusion Weighted MRI as a Predictive Biomarker of Response During Radiotherapy for High and Intermediate Risk Squamous Cell Cancer of the Oropharynx (MeRInO Stu

Brief Summary:

Around 50% of patients with locally advanced H&N cancer fail to achieve loco-regional control. Currently it cannot be predicted, during treatment, who will fall into this group of non-responders.

This study is designed to assess the value of DW MRI as a predictive biomarker of response to radiotherapy in intermediate and high risk OPSCC.